TAO Synergies (TAOX) Research & Development (2019 - 2026)

TAO Synergies has disclosed Research & Development across 8 years of filings, most recently posting $28600.0 for Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 52.97% year-over-year to $28600.0; the trailing twelve-month figure through Mar 2026 stood at $290009.0 (down 72.39% YoY), and the FY2025 full-year result was $322225.0, down 79.84% from the prior year.
• Research & Development was $28600.0 for Q1 2026 at TAO Synergies, down from $58466.0 in the prior quarter.
• Over five years, Research & Development peaked at $1.9 million in Q2 2022 and troughed at $28600.0 in Q1 2026.
• The 5-year median for Research & Development is $342068.0 (2024), against an average of $602905.8.
• The sharpest annual moves came in 2022 and 2025: Research & Development soared 96.81% in 2022, then plunged 90.02% in 2025.
• Year by year, Research & Development stood at $1.4 million in 2022, then sank by 59.1% to $577893.0 in 2023, then slipped by 26.54% to $424508.0 in 2024, then plunged by 86.23% to $58466.0 in 2025, then sank by 51.08% to $28600.0 in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $28600.0 in Q1 2026, $58466.0 in Q4 2025, and $54388.0 in Q3 2025.